Back to top

messenger-rna: Archive

Sundeep Ganoria

MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots

Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and BioNTech stocks.

PFEPositive Net Change MRNAPositive Net Change BNTXPositive Net Change

Zacks Equity Research

NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine

The FDA grants full approval to Novavax's protein-based COVID-19 vaccine after nearly a two-month delay, albeit with some new conditions.

SNYNegative Net Change PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change